CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 10, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-22
DOI
10.1038/s41419-018-1010-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer
- (2018) Cong-cong Zhu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p
- (2018) Jun Li et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes
- (2018) Youwei Zhu et al. CANCER LETTERS
- EYA1 promotes tumor angiogenesis by activating the PI3K pathway in colorectal cancer
- (2018) Shaoxin Cai et al. EXPERIMENTAL CELL RESEARCH
- H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule
- (2017) Yongfeng Song et al. HEPATOLOGY
- Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
- (2017) Jingkun Zhao et al. Molecular Cancer
- Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling
- (2017) L Xia et al. ONCOGENE
- The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation
- (2017) L-F Wang et al. ONCOGENE
- Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer
- (2017) Wei-Lan Yeh et al. Stem Cell Research & Therapy
- CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway
- (2017) Bing Xu et al. Cancer Medicine
- miR-206/133b Cluster: A Weapon against Lung Cancer?
- (2017) Jing-Yu Pan et al. Molecular Therapy-Nucleic Acids
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer
- (2016) Baochi Ou et al. CANCER LETTERS
- Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
- (2016) Hsin-An Chen et al. HEPATOLOGY
- CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling
- (2015) Mingde Zang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- CC motif chemokine ligand 19 suppressed colorectal cancer in vivo accompanied by an increase in IL-12 and IFN-γ
- (2015) Jun Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis
- (2015) Ai-Chung Mar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antitumor Efficacy of CC Motif Chemokine Ligand 19 in Colorectal Cancer
- (2014) Jun Lu et al. DIGESTIVE DISEASES AND SCIENCES
- MiR-199a-3p promotes gastric cancer progression by targeting ZHX1
- (2014) Zhenqiang Wang et al. FEBS LETTERS
- Matrix density alters zyxin phosphorylation, which limits peripheral process formation and extension in endothelial cells invading 3D collagen matrices
- (2014) Colette A. Abbey et al. MATRIX BIOLOGY
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2
- (2013) Lin Zhang et al. CANCER LETTERS
- CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
- (2013) Wei Mo et al. CELL
- A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system
- (2013) Iain Comerford et al. CYTOKINE & GROWTH FACTOR REVIEWS
- N-myc Downstream-regulated Gene 1 Promotes Tumor Inflammatory Angiogenesis through JNK Activation and Autocrine Loop of Interleukin-1α by Human Gastric Cancer Cells
- (2013) Yuichi Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/Snail signaling pathway
- (2012) Y-L Hsu et al. ONCOGENE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Investigating endothelial invasion and sprouting behavior in three-dimensional collagen matrices
- (2009) Kayla J Bayless et al. Nature Protocols
- The role of endothelial-to-mesenchymal transition in cancer progression
- (2008) S Potenta et al. BRITISH JOURNAL OF CANCER
- miR-206 Expression Is Down-regulated in Estrogen Receptor -Positive Human Breast Cancer
- (2008) N. Kondo et al. CANCER RESEARCH
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started